Prior Immune Checkpoint Inhibitor Therapy in Cancer Patients Presenting With COVID-19 Was Not Associated With Worse Outcomes but Potentially Decreased COVID-19 Related Hospitalizations and Complications: Results of a Propensity-Matched Analysis Using the O
D95. CHALLENGES AND ADVANCES IN COVID-19 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6574-A6574
10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6574